Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study
Authors:
- Najat C. DawNDNajat C. Daw
- Yueh-Yun ChiYCYueh-Yun Chi
- Elizabeth A. MullenEMElizabeth A. Mullen
- John A. KalapurakalJKJohn A. Kalapurakal
- Jing TianJTJing Tian
- Geetika KhannaGKGeetika Khanna
- James I. GellerJGJames I. Geller
- Elizabeth J. PerlmanEPElizabeth J. Perlman
- Peter F. EhrlichPEPeter F. Ehrlich
- Anne B. WarwickAWAnne B. Warwick
- Paul E. GrundyPGPaul E. Grundy
- 1 September 2019
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 118, 58-66
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 20 references indexed in Scilit:
- TP53 Mutational Status Is a Potential Marker for Risk Stratification in Wilms Tumour with Diffuse AnaplasiaPLOS ONE, 2014
- Treatment of Anaplastic Histology Wilms' Tumor: Results From the Fifth National Wilms' Tumor StudyJournal of Clinical Oncology, 2006
- Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trialThe Lancet, 2004
- Clinical and biologic significance of nuclear unrest in Wilms tumorCancer, 2003
- New definitions of focal and diffuse anaplasia in Wilms tumor: The International Society of Paediatric Oncology (SIOP) experienceMedical and Pediatric Oncology, 1999
- A note on quantifying follow-up in studies of failure timeControlled Clinical Trials, 1996
- Focal Versus Diffuse Anaplasia in Wilms Tumor—New Definitions with Prognostic SignificanceAmerican Journal of Surgical Pathology, 1996
- Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutationsNature Genetics, 1994
- Anaplasia in unilateral Wilms' tumor: A report from the National Wilms' Tumor Study Pathology CenterHuman Pathology, 1988
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958